tetano
Editor, Senior Moderator
J Med Virol
. 2021 Sep 15.
doi: 10.1002/jmv.27337. Online ahead of print.
Genetic drift in the genome of SARS COV-2 and its global health concern
Iqra Bano[SUP] 1 [/SUP], Mehmoona Sharif[SUP] 2 [/SUP], Sadia Alam[SUP] 1 [/SUP]
Affiliations
Abstract
The outbreak of the current coronavirus disease (COVID-19) occurred in late 2019 and quickly spread all over the world. The Severe Acute Respiratory Syndrome Coronavirus-2 belongs to a genetically diverse group that mutates continuously leading to emergence of multiple variants. Although, few antiviral agents and anti-inflammatory medicines are available, thousands of individuals have passed away due to emergence of new viral variants. Thus, proper surveillance of the SARS-CoV-2 genome is needed for the rapid identification of developing mutations over time which are of the major concerns if occur specifically in the surface spike proteins of the virus (neutralizing analyte). This article reviewed the potential mutations acquired by the SARS-CoV2 since pandemic began and their significant impact on the neutralizing efficiency of vaccines and validity of the diagnostic assays. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; genetics; mutation; serodiagnosis; vaccination; variants.
. 2021 Sep 15.
doi: 10.1002/jmv.27337. Online ahead of print.
Genetic drift in the genome of SARS COV-2 and its global health concern
Iqra Bano[SUP] 1 [/SUP], Mehmoona Sharif[SUP] 2 [/SUP], Sadia Alam[SUP] 1 [/SUP]
Affiliations
- PMID: 34524697
- DOI: 10.1002/jmv.27337
Abstract
The outbreak of the current coronavirus disease (COVID-19) occurred in late 2019 and quickly spread all over the world. The Severe Acute Respiratory Syndrome Coronavirus-2 belongs to a genetically diverse group that mutates continuously leading to emergence of multiple variants. Although, few antiviral agents and anti-inflammatory medicines are available, thousands of individuals have passed away due to emergence of new viral variants. Thus, proper surveillance of the SARS-CoV-2 genome is needed for the rapid identification of developing mutations over time which are of the major concerns if occur specifically in the surface spike proteins of the virus (neutralizing analyte). This article reviewed the potential mutations acquired by the SARS-CoV2 since pandemic began and their significant impact on the neutralizing efficiency of vaccines and validity of the diagnostic assays. This article is protected by copyright. All rights reserved.
Keywords: COVID-19; SARS-CoV-2; genetics; mutation; serodiagnosis; vaccination; variants.